Ursodiol-Methotrexate for Primary Biliary Cirrhosis
Public ClinicalTrials.gov record NCT00006168. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The major thrust is to determine whether treatment of patients with Primary Biliary Cirrhosis (PBC) with Ursodiol (Ursodeoxycholic Acid-UDCA) plus methotrexate (MTX) is more effective than treatment with UDCA alone.
Study identification
- NCT ID
- NCT00006168
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 20 Years to 69 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 1994 (Type not available)
- Primary completion
- Not listed
- Completion
- Mar 2004 (Type not available)
- Last update posted
- Jan 13, 2010
1994 – 2004
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Keck School of Medicine at U.S.C. | Los Angeles | California | 90033 | — |
| U California Medical Center | San Francisco | California | 94143 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06520-8019 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | — |
| Saint Louis University | St Louis | Missouri | 63104 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198-3285 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Oregon Health Sciences University | Portland | Oregon | 97201 | — |
| Albert Einstein Medical Center | Philadelphia | Pennsylvania | 19141 | — |
| UT Southwestern Medical Center at Dallas | Dallas | Texas | 75235-9151 | — |
| Medical College of Virginia | Richmond | Virginia | 23298-0711 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00006168, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2010 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00006168 live on ClinicalTrials.gov.